Searched for
MAHIMA DATLA
Savitri Jindal tops again, Biological E's Mahima Datla joins Forbes' rich list; Here are top nine richest womenIndia's wealthiest list sees nine women featured in 2024, led by Savitri Jindal with a net worth of $43.7 billion. Notable names include Re...- Corbevax vaccine gets WHO Emergency Use Listing authorisationThe company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, ...
- Biological E plans to hive off non-vaccine business and sell stakeAccording to rating firm ICRA, BE reported revenues of Rs 2,556.8 crore in FY22, largely driven by the government's Rs 1,500-crore contract...
- Biological E to invest Rs 1800 crore to augment vaccine capacity, injectables, R&DAccording to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...
- Biological E to get mRNA technology from WHO to make COVID-19VaccinesWHO along with its partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and su...
- Corbevax to cost Rs 800 in market & Rs 145 for the govt"Our price to the government programme is ₹145, the lowest in the country and possibly the world," Datla said. "It's something we take grea...
- New Covid vaccine: Bio E may submit Corbevax trial data this monthThe government had estimated that Biological would account for 300 million jabs from August to December.
- BE hopes to roll out COVID-19 vaccine Corbevax by November-endSpeaking to reporters on the sidelines of signing a financing agreement with US International Development Finance Corporation (DFC), she sa...
- Biological E gets nod for phase 2/3 clinical trial of its Covid vaccine on children above 5 years, adolescentsThe approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...
- Mansukh Mandaviya holds meeting with Biological-E MD on progress of Covid vaccine Corbevax"Met Ms Mahima Datla, MD of @Biological_E , who briefed me on the progress of their upcoming #COVID19 vaccine, Corbevax. I assured all the ...
- Biological E plans to break into the big league by manufacturing three Covid-19 vaccinesOf these, the phase-three trials of Corbevax — jointly manufactured by BE, Baylor College of Medicine in Houston and Dynavax in California ...
- Biological E signs pact to manufacture Providence vaccineUnder the agreement, Providence will provide the necessary technology transfer for Biological E to manufacture mRNA vaccines in India with ...
- Dynavax to supply its CpG 1018 adjuvant for Biological E's COVID-19 Vaccine CandidatePending conditional regulatory approvals in India, BE expects to commence product launch of Corbevax later this year.
- Indian vaccine makers say can quickly adapt to tackle variantsIn all, India has reported more than 11 million coronavirus infections, the highest number in the world after the United States, and about ...
- Biological E to start phase-III trials by January, license vaccine by summerDisclosing this in Hyderabad on Monday, managing director Mahima Datla said the company is currently evaluating four different formulations...
- Biological E signs pact with J&J for Covid-19 vaccine technologyBiological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...
- India seems to be getting closer to an antidote, even as the coronavirus situation worsensThis week India overtook the US in daily addition of new COVID-19 cases. It is worrying. The World Health Organization says that the infect...
- Indian companies making Covid-19 vaccine upset over lack of norms and infrastructureIndia is staring at the risk of losing its competitive advantage in vaccine manufacturing to other countries, Biological E chairperson said...
- Biological E may raise 620 crore via stake saleVaccine company Biological E plans to raise about Rs 620 crore by selling up to 25% stake to financial or strategic investors.
- Agreement with Biological E to lower cost of vaccine: GAVIGAVI Alliance was created in 2000 to accelerate the introduction of new vaccines so that all children.
Load More
